N@N

NOVA, MWIV, HERO, HWAY, MHGC, OPTR Expected to Trade Down After Bearish Patterns Develop

April 18, 2011 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring top technical trading patterns and these stocks are the most likely to trade Down in the coming weeks. NOVAMED INC (NASDAQ:NOVA), MWI VETERINARY SUPPLY INC (NASDAQ:MWIV), HERCULES OFFSHORE INC (NASDAQ:HERO), HEALTHWAYS INC (NASDAQ:HWAY), MORGANS HOTEL GROUP CO (NASDAQ:MHGC), OPTIMER PHARMACEUTICALS INC (NASDAQ:OPTR) are all expected to go Down as Bearish signals have been generated by top technical trading patterns. We monitor these patterns: Support Break, Support Reversal, Breakaway Gap, Measured Gap, Exhaustion Gap, Resistance Break, Resistance Reversal, Saucer Reversal, Volume Climax, Volume Trend, Fibonacci Reversal, Consolidation Breaks, Trend Line Break,Trend Line Reversal, Candles, Golden Crosses, Death Crosses and more. The chart below displays the stocks expected to go Down along with pattern, strategy and strength ratings.

     Symbol     Company                             Strategy                            Pattern Name            Strength  
     NOVA       NOVAMED INC                         Reversal (Stocks) DWC               Trend Line Reversal(5+)     4         
     MWIV       MWI VETERINARY SUPPLY INC           Reversal (Stocks) DWC               Resistance Break(1)     4         
     HERO       HERCULES OFFSHORE INC               Reversal (Stocks) DWC               38 % Retracement        5         
     HWAY       HEALTHWAYS INC                      Breakout (Stocks) DO                Trend Line Break(3)     2         
     MHGC       MORGANS HOTEL GROUP CO              Breakout (Stocks) DO                Support Reversal(2)     2         
     OPTR       OPTIMER PHARMACEUTICALS INC         Reversal (Stocks) DWC               Trend Line Reversal(5+)     3         

Chart Pattern Recognition is based on a 20-year patterns database. This database is used to determine pattern strength for patterns as they appear. There is no optimization and the pattern signals never change. For each pattern variation, we record accuracy and profitability statistics in a patterns database. From this information, we are able to define strength ratings from 1 to 5. The '1' rating shows ALL patterns while a '5' rating shows the best patterns according to profitability. Each pattern has its own strength rating factors. The result is an automatic ranking system that allows us to only show the BEST patterns. You can see that, at Strength 5, virtually all the patterns are profitable. The pattern strength rating system separates the most profitable patterns. The specific technology used to make these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/sw/ot.php

NOVAMED INC (NASDAQ:NOVA) - NovaMed, Inc., together with its subsidiaries, owns and operates ambulatory surgery centers (ASCs) in the United States. It also owns and operates optical laboratories, an optical products purchasing organization, a marketing products and services business, a call center, and marketing solutions business. The companys physicians perform various surgical procedures in ASCs, which include ophthalmology, orthopedics, pain management, gastroenterology, urology, ENT, plastic surgery, and gynecology. In addition, NovaMed, Inc. provides management services to eye care practices, which include an optometric practice with an optical retail store located in the Chicago market; and an ophthalmology practice with various locations in Atlanta, Georgia. These services comprise business, information technology, administrative, and financial services. As of March 15, 2010, it owned and operated 37 ASCs located in 19 states. Further, the company provides a range of products and services, such as brochures, videos, advertising and Website design, education and training programs, and consulting services to eye care professionals and vendors; and manufactures and distributes corrective lenses and eyeglasses to affiliated and non-affiliated ophthalmologists and optometrists. The company was formerly known as NovaMed Eyecare, Inc. and changed its name to NovaMed, Inc. in March 2004. NovaMed, Inc. was founded in 1995 and is based in Chicago, Illinois.

MWI VETERINARY SUPPLY INC (NASDAQ:MWIV) - MWI Veterinary Supply, Inc. distributes animal health products to veterinarians in the United States. The company primarily offers pharmaceuticals, vaccines, parasiticides, diagnostics, capital equipment, supplies, specialty products, veterinary pet food, and nutritional products. Its pharmaceutical products include anesthetics, analgesics, antibiotics, ophthalmics, and hormones; and vaccine products comprise small animal, equine, and production animal biologicals. The companys diagnostic products consist of consumable in-clinic tests for detecting heartworm, lyme, feline leukemia, and parvovirus, as well as consumable products for measuring blood chemistry, electrolyte balance, and cell counts; capital equipment products include anesthesia machines, surgical monitors, diagnostic equipment, dental machines, cages, lights, and x-ray machines; and supplies comprise syringes, instruments, bandages, IV products, surgical consumables, grooming materials, and other small equipment items. Its veterinary pet food products consist of foods for specialty diets and premium pet foods; and nutritional products include dietary supplements, vitamins, dental chews, and specialty treats. The companys parasiticides are used for controlling fleas, ticks, flies, mosquitoes, and internal parasites. As of September 30, 2009, it served approximately 20,000 veterinary practices. The company was formerly known as MWI Holdings, Inc. and changed its name to MWI Veterinary Supply, Inc. in April 2005. MWI Veterinary Supply, Inc. was founded in 1976 and is headquartered in Meridian, Idaho.

HERCULES OFFSHORE INC (NASDAQ:HERO) - Hercules Offshore, Inc., together with its subsidiaries, provides shallow-water drilling and marine services to the oil and natural gas exploration and production industry in the U.S. Gulf of Mexico and internationally. The company serves integrated energy companies, independent oil and natural gas operators, and national oil companies. As of February 24, 2010, it owned a fleet of 30 jackup rigs, 17 barge rigs, 3 submersible rigs, 1 platform rig, a fleet of marine support vessels, and 60 liftboat vessels, as well as owned 4 retired jackup rigs and 10 retired inland barges located in the U.S. Gulf of Mexico. The company was founded in 2004 and is based in Houston, Texas.

HEALTHWAYS INC (NASDAQ:HWAY) - Healthways, Inc. provides specialized, comprehensive solutions to assist people in maintaining or improving their health and well-being. Its solutions are designed to assist healthy individuals stay healthy, mitigate, and slow the progression of disease associated with family or lifestyle risk factors; and promote the possible health for those already affected by disease. The companys evidence-based programs provide specific and personalized interventions for each individual in a population, irrespective of age or health status, and are delivered to consumers by phone, mail, Internet, and face-to-face interactions. Healthways, Inc. also provides a national, fully accredited complementary and alternative Health Provider Network, and a national Fitness Center Network, offering access to individuals who seek health services outside of, and in conjunction with, the traditional healthcare system. The company delivers its programs to various customers, including health plans, governments, employers, pharmacy benefit managers, and hospitals in the United States and internationally. It operates care enhancement and coaching centers staffed with licensed health professionals, as well as a network of complementary and alternative medicine and chiropractic practitioners. The company was founded in 1981 and is headquartered in Franklin, Tennessee.

MORGANS HOTEL GROUP CO (NASDAQ:MHGC) - Morgans Hotel Group Co., a hospitality company, engages in the ownership, operation, acquisition, development, and redevelopment of boutique hotels in gateway cities and resort markets primarily in the United States and Europe. The company owns and manages Morgans, Royalton, and Hudson hotels in New York, New York; Delano South Beach, Mondrian South Beach, and Shore Club hotels in Miami, Florida; Mondrian Los Angeles hotel in Los Angeles, California; Clift hotel in San Francisco, California; Mondrian Scottsdale hotel in Scottsdale, Arizona; St. Martins Lane and Sanderson hotels in London, the United Kingdom; Hard Rock hotel and casino in Las Vegas, Nevada; and Ames hotel in Boston, Massachusetts. As of December 31, 2009, it owned, or partially owned, and managed a portfolio of 13 luxury hotel properties comprising approximately 4,700 rooms. The company was incorporated in 2005 and is headquartered in New York, New York.

OPTIMER PHARMACEUTICALS INC (NASDAQ:OPTR) - Optimer Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing anti-infective products worldwide. It develops products that treat gastrointestinal infections and related diseases. The companys two late-stage anti-infective product candidates include Fidaxomicin, the lead product candidate and an antibiotic for the treatment of clostridium difficile-infections, which completed two Phase III clinical trial; and Prulifloxacin, a prodrug in the fluoroquinolone class of antibiotics, which completed two Phase III trials for the treatment of infectious diarrhea, including travelers diarrhea. It also develops product candidates using its proprietary technology Optimer One-Pot Synthesis, a drug discovery platform and a computer-aided technology that enables the synthesis of carbohydrate-based compounds. In addition, the companys other pipeline product candidates consist of CEM-101 (OP-1068), a macrolide and ketolide antibiotic for the treatment of upper and lower respiratory tract infections; OPT-88, a disease-modifying intra-articular therapy for osteoarthritis; and OPT-822/OPT-821, a carbohydrate-based immunostimulant therapy for the treatment of metastatic breast cancer. Additionally, it licensed rights to Cempra Pharmaceuticals, Inc. to develop CEM-101; and granted rights to Optimer Biopharmaceuticals, Inc. to develop OPT-88 and OPT-822/821. Further, the company has collaborative agreements with Par Pharmaceuticals, Inc.; Nippon Shinyaku, Co., Ltd.; Memorial Sloan-Kettering Cancer Center; and Scripps Research Institute. Optimer Pharmaceuticals was founded in 1998 and is based in San Diego, California.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net